CD4 and small cell lung carcinoma: The present study showed that infiltration/expression levels of CD4 and CD8‐positive T lymphocytes and TGFβ1 and SMAD3 were associated with survival from the initiation of the combined therapy with chemotherapy plus immune checkpoint inhibitors in patients with SCLC.